FDA clearance is a milestone, not a revenue strategy. I help medical device founders and CEOs build the commercial system that turns clinical evidence into the right positioning, qualified demand, sales enablement, account adoption, and measurable growth, without hiring a full-time CMO.
Your team may have achieved clearance and built a strong product, but the route to revenue still crosses clinicians, economic buyers, hospital committees, procurement, distributors, and internal execution. When strategy, sales, marketing, and agencies move separately, opportunities stall and budgets get spent without a clear path to adoption.
The solution is one accountable commercial marketing leader connecting the entire system.
• Choose the beachhead specialty, care setting, and ideal customer profile • Translate clinical evidence and approved claims into buyer-specific positioning • Map physicians, value analysis, procurement, finance, and distributor decision paths • Build a device go-to-market plan with commercial milestones and owners • Lead sales enablement, agency strategy, digital demand, and channel priorities • Coordinate with regulatory, clinical, quality, and reimbursement specialists • Set budgets, pipeline stages, acquisition economics, and executive KPIs • Align sales and marketing around evaluations, first use, and repeat adoption
.jpg)

Days 1 to 30: Diagnose. Review market segmentation, clinical and economic evidence, claims, sales pipeline, customer interviews, agencies, and adoption barriers. Deliver a prioritized commercialization diagnosis. Days 31 to 60: Architect. Build the go-to-market roadmap, stakeholder messaging, sales-enablement priorities, execution budget, KPI scorecard, and owner matrix. Days 61 to 90: Activate. Run focused commercial pilots, support evaluations, improve sales handoffs, and report what moved and what remains blocked. Deliverables include a 90-day roadmap, executive dashboard, budget and channel plan, accountable owners, and next-quarter investment decisions. Hospital purchase cycles may extend beyond 90 days.
I focus reporting on the buyer's next real step, not a dashboard full of ad clicks. In the first 90 days we baseline the funnel, define ownership, and measure progress across the sales and adoption journey.
Target accounts engaged, relevant physician and buyer conversations, sales-accepted opportunities, and cost per qualified evaluation.
Evaluation starts and completions, stakeholder buy-in, procurement steps, training, time to first clinical use, and repeat utilization where relevant.
Approved budget, pipeline-stage conversion, attributed and influenced revenue reported separately, contribution margin, and the cost of moving accounts through the commercial process.
For FDA-cleared, approved, or otherwise appropriately marketable device companies preparing to launch, expanding into new specialties, struggling to convert evaluations into orders, or coordinating multiple sales and marketing partners. Best fit: a founder or CEO with a viable product and execution resources who needs senior leadership, but not a full-time CMO yet.

Fractional CMO engagements begin at $7,500 per month, with an initial 90-day leadership period. A more embedded scope may cost more depending on company complexity, market coverage, team size, agency management, and the degree of implementation oversight. The final proposal defines the scope and executive availability.
The leadership fee covers strategy and executive oversight, not an unlimited production team. Creative, media, research, travel, clinical or reimbursement specialists, and paid campaigns are provided by your team or separately scoped. We begin with a conversation to determine whether you need a diagnostic, a 90-day plan, or ongoing leadership.
Built for Growth Decisions, Not Vanity Metrics
Since 1999, my work has spanned healthcare, medical devices, direct response, paid acquisition, conversion, and executive growth leadership, including a reported $139M+ in revenue impact across recent engagements. I focus on accountable priorities, commercial economics, and transparent reporting. No credible CMO can promise hospital purchasing decisions on a fixed 90-day clock.
I own marketing direction, market priorities, budgets, positioning, agency leadership, team coordination, and the executive scorecard. Your regulatory, clinical, legal, and reimbursement specialists retain their professional approval roles. Your team and scoped partners execute campaigns, design, development, and field programs. The goal is qualified evaluations, faster progress through real buyer milestones, and sustainable adoption.
Not ready for ongoing leadership? Start with the Growth Clarity Diagnostic to identify the biggest commercialization constraint before committing to a longer engagement.
Use these CEO-level guides to understand the decisions, fees, and regulatory milestones that shape your go-to-market plan.
The full commercialization roadmap, including hospital buying committees, reimbursement considerations, a 90-day plan, a six-month illustrative budget, and executive KPIs.
Transparent published pricing, engagement models, the first 90 days of work, and the questions CEOs should ask before hiring.
Review the regulatory pathways and launch-planning decisions that should be coordinated with medical, quality, regulatory, and legal professionals.
MEDICAL DEVICE FRACTIONAL CMO FAQS
Clear answers about commercialization leadership, launch support, 90-day outcomes, compliance boundaries, and fees.
When you have an appropriately marketable device and real commercial decisions to manage, but not enough workload or budget for a full-time executive. The strongest fit is a company that needs one leader to align positioning, sales enablement, channels, agency work, and adoption measurement.
A commercialization diagnosis and baseline, prioritized market-entry roadmap, stakeholder and message map, budget and KPI scorecard, sales enablement priorities, and a first wave of supervised execution. The goal is a more repeatable commercial operating system, not a guaranteed 90-day hospital sale.
I coordinate commercialization messaging and the approval process with your regulatory, legal, quality, clinical, and reimbursement experts. I do not replace those professionals, determine clinical claims, or provide legal or regulatory advice.
Yes. I help set priorities, clarify ownership, direct internal and external marketing resources, and coordinate with sales leadership. Execution and specialist services remain with your team, existing agencies, or separately scoped providers.
Depending on your model: qualified target accounts, buyer and physician engagement, evaluation starts and completions, procurement milestones, trained accounts, first use, repeat utilization, revenue, contribution margin, and commercial spend. We define the metrics and attribution rules before scaling.
Engagements begin at $7,500 per month with an initial 90-day period. Price varies with executive time, commercialization complexity, number of markets, and oversight needs. Media, content production, specialist regulatory or clinical work, and other execution costs are separate unless specifically scoped.
See what 50 direct-to-consumer healthcare companies reveal about pricing, funnels, recurring revenue, async care, infrastructure, and authority.
Get the Free BenchmarkOriginal research from Charles Kirkland